Interestingly, deletion of Jag1—but not the canonical Notch effector Rbpj—in APC-deficient Lgr5+ cells disrupted the Paneth-cell tumour niche and compromised adenoma growth, suggesting non-canonical Notch signalling as a prospective therapeutic target [365]. This evidence concerns the gene LGR5 and adenoma.